Biopolym. Cell. 1990; 6(2):55-60.
Analysis of restriction polymorphism of D7S23 locus by polymerase chain reaction with KM-19 probe in population and cystic fibrosis families
1Ivashchenko T. E., 1Gorbunova V. N., 1Aseev M. V., 1Baranov V. S., 2Vinogradov S. V., 3Berlin Yu. A., 1Goltzov A. A., 2Kaboev O. K., 2Schwartz E. I.
  1. Institute of Obstetrics and Gynecology, Academy of Medical Sciences of the USSR
    Leningrad, USSR
  2. B. P. Konstantinov Institute of Nuclear Physics, Academy of Sciences of the USSR
    Gatchina, Leningrad distr., USSR
  3. M. M. Shemyakin Institute of Bioorganic Chemistry, Academy of Sciences of the USSR
    Moscow, USSR


Highly significant disequilibrium of Al and A2 allelcs rate in population (group I), CF-heterozygotes (group II) and CF patients (group III) has been found with KM-19 probe in polymerase chain reaction, that constitutes 75 % and 25 % for 46 individuals in gr. I, 48 % and 52 % for 51 individuals in gr. II, 0 % and 100 % in 18 individuals of gr. Ill, respectively. These data prove highly nonrandom linkage of A2 allele of KM-19 with CF-gene and Al allele with normal gene and thus significantly extend the capacity of molecular approaches for prenatal diagnosis of CF during early development as well as for CF heterozygotes detection and CF diagnosis postnatally. Some methodological improvements in polymerase chain reaction are discussed.


[1] Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230(4732):1350-4.
[2] Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239(4839):487-91.
[3] Scharf SJ, Horn GT, Erlich HA. Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science. 1986;233(4768):1076-8.
[4] Kogan SC, Doherty M, Gitschier J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med. 1987;317(16):985-90.
[5] Feldman GL, Williamson R, Beaudet AL, O'Brien WE. Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism. Lancet. 1988;2(8602):102.
[6] Sommer SS, Sobell JL. Application of DNA-based diagnosis to patient care: the example of hemophilia A. Mayo Clin Proc. 1987;62(5):387-404.
[7] Kapranov NI. Author. dis. ... Dr. med. Sci. Moscow, Institute of Pediatrics, USSR Academy of Medical Sciences. 1986; 37 p.
[8] Morris M., Super M. Cystic fibrosis. The facts. Oxford: Univ. press, 1987. 264 p.
[9] Speer A, Davies K, McGlade S, Hanke R, Spiegler AW, Szibor R, Sommer D, Herrmann F, Coutelle C. Possibilities and problems in genomic diagnosis of Duchenne muscular dystrophy with molecular probes. Biomed Biochim Acta. 1986;45(7):K19-27.
[10] Estivill X, Farrall M, Williamson R, Ferrari M, Seia M, Giunta AM, Novelli G, Potenza L, Dallapicolla B, Borgo G, et al. Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study. Am J Hum Genet. 1988;43(1):23-8.
[11] Shvarts EI, Kaboev OK, Gol'tsov AA, Vinogradov SV, Lebedenko EN. Primer-dependent amplification of 2 sites of human beta-globin gene. Bioorg Khim. 1988;14(11):1577-9.